Erratum to "Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: stronger evidence, greater trust": [Annals of Oncology 32 (2021) 1077-1082].

Piccart, M J; Kalinsky, K; Gray, R; Barlow, W E; Poncet, C; Cardoso, F; Winer, E; Sparano, J

Erratum to "Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: stronger evidence, greater trust": [Annals of Oncology 32 (2021) 1077-1082].

Piccart, M J; Kalinsky, K; Gray, R; Barlow, W E; Poncet, C; Cardoso, F; Winer, E; Sparano, J.

Affiliation

Piccart MJ; Institut Jules Bordet Brussels, Université Libre de Bruxelles (ULB), Belgium; Breast International Group(BIG)-aisbl, Brussels, Belgium. Electronic address: martine.piccart@bordet.be.
Kalinsky K; Winship Cancer Institute, Emory University, Atlanta.
Gray R; Department of Data Science, Dana-Farber Cancer Institute, Boston.
Barlow WE; SWOG Statistics and Data Management Centre, Seattle, USA.
Poncet C; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.
Cardoso F; Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Lisbon, Portugal.
Winer E; Dana-Farber Cancer Institute, Harvard Medical School, Boston.
Sparano J; Albert Einstein Cancer Center, Montefiore Medical Center, Bronx, USA.

Ann Oncol ; 33(6): 668, 2022 Jun.

Article de En | MEDLINE | ID: mdl-35487836

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2022 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google